(Q54055760)

24 May 2018

title

Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study. (English)

1 reference

24 May 2018

author

Antonino De Paoli

6

1 reference

24 May 2018

author name string

C Tondini

1

1 reference

24 May 2018

M Balzarotti

2

1 reference

24 May 2018

I Rampinelli

3

1 reference

24 May 2018

P Valagussa

4

1 reference

24 May 2018

M Luoni

5

1 reference

24 May 2018

A Santoro

7

1 reference

24 May 2018

G Bonadonna

8

1 reference

24 May 2018

publication date

1 February 2000

1 reference

24 May 2018

published in

Annals of Oncology

1 reference

24 May 2018

volume

11

1 reference

24 May 2018

page(s)

231-233

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

Prolonged disease-free survival in relapsed/refractory low-grade lymphoma treated with fludarabine: a report of four cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008325110921

7 January 2021

Identifiers

DOI

10.1023/A:1008325110921

1 reference

24 May 2018

PubMed ID

10761763

1 reference

24 May 2018